ArticleThe pharmacogenomics journal2017

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses.

D Kringel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.